Small- and medium-sized drug makers call for delay planned GMP regulations

The Korea Pharmaceutical Industry Cooperation (KPIC), a lobby group of 200 small- and medium-sized pharmaceutical firms, said on November 7 that the government's proposed global standard GMP (cGMP) be postponed until all requirements would be met.

In a statement delivered to the National Assembly and government agencies, the KPIC claimed that the nation's small- and medium-sized drug makers ...